12.09.2022 Ecraid partners with Valneva for a COVID-19 booster vaccine trial Ecraid has begun its first clinical trial in partnership with specialty vaccine company Valneva.
6.09.2022 Pablo Martínez Aguado’s quest for prioritising wellbeing in research Pablo Martínez Aguado is a project manager for Ecraid’s POS-cUTI study. We spoke to him about his invaluable time working and le…
31.08.2022 Ecraid and ESCMID join forces for a workshop on clinical research methods The postgraduate technical workshop will take place from 20–22 October 2022 in Utrecht. Registration is open until 22 September.
25.08.2022 Ecraid intensifies efforts against monkeypox Ecraid augments its response to the expanding monkeypox outbreak in Europe proportionate to the current perceived risk.
9.08.2022 New publication makes the case for Perpetual Observational Studies (POS) New peer-reviewed paper makes a convincing case for a novel concept in clinical research: Perpetual Observational Studies (POS).
9.08.2022 Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases
